GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **326 - 350** of **4050** in total

« First

‹ Prev

…

10

11

12

13

14

15

16

17

18

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 2	15	mild	G15407YE	1896
IgG	Patient 2	3	mild	G41200QS	1878
IgG	Patient 3	-180	mild	G12200GB	1857
IgG	Patient 4	12	mild	G82096UQ	1847
IgG	Patient 3	4	mild	G26125KY	1842
IgG	Patient 4	12	mild	G60761LT	1840
IgA	Patient 3	11	mild	G26295XE	1839
IgA	Patient 2	3	mild	G21675ZL	1838
IgA	Patient 3	4	mild	G51175PR	1834
IgA	Patient 3	4	mild	G43648DB	1827
IgM	Patient 3	4	mild	G64669AQ	1821
IgA	Patient 2	15	mild	G42666HT	1810
IgM	Patient 4	12	mild	G68461PT	1804
IgA	Patient 2	15	mild	G25559RS	1802
IgM	Patient 4	12	mild	G17390SF	1796
IgM	Patient 3	11	mild	G42666HT	1794
IgM	Patient 2	3	mild	G80587NA	1793
IgG	Patient 3	-180	mild	G60761LT	1788
IgG	Patient 3	11	mild	G26125KY	1785
IgG	Patient 3	11	mild	G76615YG	1785
IgM	Patient 2	24	mild	G80587NA	1761
IgM	Patient 3	4	mild	G35446HX	1747
IgG	Patient 2	3	mild	G31265MS	1728
IgM	Patient 4	12	mild	G17140UR	1716
IgG	Patient 3	4	mild	G76615YG	1694